Cargando…

Érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie

The erysipelas is a bacterial infection most frequently due to (85% of cases) streptococcus β-hemolytic of group A (SGA), resulting in non-necrotizing dermo-hypodermitis. Many factors may play a role in its occurrence such as general factors: diabetes, immunosuppression, chemotherapy, radiotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbach, Younes, Mernissi, Fatima Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814916/
https://www.ncbi.nlm.nih.gov/pubmed/31692767
http://dx.doi.org/10.11604/pamj.2019.33.248.16771
_version_ 1783463088073211904
author Barbach, Younes
Mernissi, Fatima Zahra
author_facet Barbach, Younes
Mernissi, Fatima Zahra
author_sort Barbach, Younes
collection PubMed
description The erysipelas is a bacterial infection most frequently due to (85% of cases) streptococcus β-hemolytic of group A (SGA), resulting in non-necrotizing dermo-hypodermitis. Many factors may play a role in its occurrence such as general factors: diabetes, immunosuppression, chemotherapy, radiotherapy as well as locoregional ports of entry such as leg ulcer, an insect bite, intertrigo. The occurrence of erysipelas associated with recurrent squamous cell carcinoma after radiochemotherapy is exceptional, requiring early treatment of dermo-hypodermitis as well as suitable and multidisciplinary management of the carcinoma. The mechanism of the occurrence of erysipelas after radiotherapy coincides with its pathophysiology. Indeed, this therapeutic component, which is very used to treat squamous cell carcinoma, alters lymphatic drainage resulting, very gradually, in lymph fibrosis thus weakening the defense mechanism. Its association with alteration of cellular immunity, also favored by radiotherapy and chemotherapy, can cause the occurrence of erysipelas in these patients. We report the case of a 50-year old female patient with a 1-year history of squamous cell carcinoma of the right labium majus treatment with radiochemotherapy with remission. Eight months later, the patient had recurrence. Evolution was marked by the appearance of a painful hot erythematous plaque on the right thigh suggesting erysipelas, confirmed by laboratory tests which showed an infection. The patient was put on antibiotic therapy with good improvement and then referred to the Department of Oncology for recurrence management.
format Online
Article
Text
id pubmed-6814916
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-68149162019-11-05 Érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie Barbach, Younes Mernissi, Fatima Zahra Pan Afr Med J Images in Medicine The erysipelas is a bacterial infection most frequently due to (85% of cases) streptococcus β-hemolytic of group A (SGA), resulting in non-necrotizing dermo-hypodermitis. Many factors may play a role in its occurrence such as general factors: diabetes, immunosuppression, chemotherapy, radiotherapy as well as locoregional ports of entry such as leg ulcer, an insect bite, intertrigo. The occurrence of erysipelas associated with recurrent squamous cell carcinoma after radiochemotherapy is exceptional, requiring early treatment of dermo-hypodermitis as well as suitable and multidisciplinary management of the carcinoma. The mechanism of the occurrence of erysipelas after radiotherapy coincides with its pathophysiology. Indeed, this therapeutic component, which is very used to treat squamous cell carcinoma, alters lymphatic drainage resulting, very gradually, in lymph fibrosis thus weakening the defense mechanism. Its association with alteration of cellular immunity, also favored by radiotherapy and chemotherapy, can cause the occurrence of erysipelas in these patients. We report the case of a 50-year old female patient with a 1-year history of squamous cell carcinoma of the right labium majus treatment with radiochemotherapy with remission. Eight months later, the patient had recurrence. Evolution was marked by the appearance of a painful hot erythematous plaque on the right thigh suggesting erysipelas, confirmed by laboratory tests which showed an infection. The patient was put on antibiotic therapy with good improvement and then referred to the Department of Oncology for recurrence management. The African Field Epidemiology Network 2019-07-23 /pmc/articles/PMC6814916/ /pubmed/31692767 http://dx.doi.org/10.11604/pamj.2019.33.248.16771 Text en © Younes Barbach et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Images in Medicine
Barbach, Younes
Mernissi, Fatima Zahra
Érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie
title Érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie
title_full Érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie
title_fullStr Érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie
title_full_unstemmed Érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie
title_short Érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie
title_sort érysipèle sur carcinome épidermoïde récidivant de la grande lèvre après radio-chimiothérapie
topic Images in Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814916/
https://www.ncbi.nlm.nih.gov/pubmed/31692767
http://dx.doi.org/10.11604/pamj.2019.33.248.16771
work_keys_str_mv AT barbachyounes erysipelesurcarcinomeepidermoiderecidivantdelagrandelevreapresradiochimiotherapie
AT mernissifatimazahra erysipelesurcarcinomeepidermoiderecidivantdelagrandelevreapresradiochimiotherapie